Cure8 research brief
Cure8 research brief
Sarcopenia (low muscle strength and mass) was linked to higher risk of IBD-related hospitalization and infections over 12 months, so assessing muscle status may help identify patients at higher short-term risk. Recognizing sarcopenia could prompt nutritional or physical interventions and closer monitoring.
Adults with Crohn’s disease or ulcerative colitis; gastroenterology clinicians, IBD dietitians, and researchers focused on nutrition/body composition in IBD.
This study enrolled 113 adults with IBD and used handgrip strength plus bioelectrical impedance analysis (BIA) to classify patients as non-sarcopenic, probable sarcopenia, or confirmed sarcopenia.
Confirmed sarcopenia (7.1% of the cohort) was linked to higher rates of IBD-related hospitalization and infectious complications over 12 months, and these associations remained after adjusting for some clinical factors. The authors report confirmed sarcopenia was associated with lower BMI, higher CRP, and higher nutritional risk.
Confirmed sarcopenia predicted a markedly increased adjusted odds of hospitalization and infectious complications; there was no independent link to general clinical worsening after multivariable adjustment.
These results suggest measuring muscle strength and mass (handgrip and BIA) can add prognostic information beyond routine disease activity and nutrition assessments in IBD.
Findings come from a prospective cohort reported in the article abstract; the confirmed sarcopenia group was small (n=8), so results should be interpreted cautiously. Associations do not prove causation.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.